Friday, June 20, 2025
25.3 C
Bengaluru

Indian Pharma Regional Performance Analysis & Summary

Overall Market Performance (IPM)
• The Indian Pharmaceutical Market (IPM) recorded a total value of ₹229,260.6 crore, with an overall growth of 7.6% for Dec’24.
• Out of 26 regions, 12 states/regions grew faster than the IPM growth rate of 7.6%, while the rest grew equal to or slower.

Regional Zone-Wise Performance
1. North Zone (₹62,928.3 Cr, 27% MS, 8.0% Growth)
• Top Contributors: Uttar Pradesh (₹25,550.2 Cr, 41% MS), Delhi (₹10,756.3 Cr, 17% MS).
• Fastest Growing: Delhi (12.5%), Jammu & Kashmir (9.4%), Haryana (8.8%).
2. South Zone (₹60,758.9 Cr, 27% MS, 7.1% Growth)
• Top Contributors: Karnataka (₹13,486.8 Cr, 22% MS), Tamil Nadu (₹11,509.0 Cr, 19% MS).
• Fastest Growing: Chennai (11.6%), Telangana (8.9%), Tamil Nadu (8.2%).
3. East Zone (₹56,501.1 Cr, 25% MS, 7.4% Growth)
• Top Contributors: West Bengal (₹14,651.3 Cr, 26% MS), Bihar (₹12,078.9 Cr, 21% MS).
• Fastest Growing: Chhattisgarh (9.5%), Orissa (8.7%), Assam (7.6%).
4. West Zone (₹49,072.3 Cr, 21% MS, 8.0% Growth)
• Top Contributors: Maharashtra (₹19,780.5 Cr, 40% MS), Madhya Pradesh (₹10,154.7 Cr, 21% MS).
• Fastest Growing: Madhya Pradesh (9.8%), Maharashtra (8.6%), Gujarat (8.7%).

Key Highlights

✅ Fastest Growing State: Delhi (12.5%)
✅ Other High Growth Regions: Chennai (11.6%), Madhya Pradesh (9.8%)
✅ Largest Market Share Contributors: Uttar Pradesh (₹25,550.2 Cr, 41% MS), Maharashtra (₹19,780.5 Cr, 40% MS), and West Bengal (₹14,651.3 Cr, 26% MS).
✅ North and West Zones had the highest growth rate (8.0%), while the South Zone had the slowest (7.1%).

Conclusion
• Delhi, Chennai, and Madhya Pradesh were the fastest-growing states.
• North and West zones led in growth, while the South zone expanded relatively slower.
• Key markets like Uttar Pradesh, Maharashtra, and West Bengal dominate market share.
• Overall, 12 states/regions outpaced the IPM growth rate of 7.6%, showing strong market potential.

Data Source: IQVIA

Hot this week

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...

FLUX – Indian Pharma in the Post VUCA World

Introduction For decades, leaders and organizations have relied on the...

Topics

Top 25 Indian Pharma Companies by Revenues in 2024

India pharma is crucial for global healthcare, providing affordable...

Top 10 Indian Pharma – 2025

India's top 10 pharma companies by market capitalization, offering insights into...

Antibody-Drug Conjugates (ADCs): The Disruptors Leading Oncology’s Gold Rush in 2025

1. Market Overview The oncology sector remains the most dominant...

FLUX – Indian Pharma in the Post VUCA World

Introduction For decades, leaders and organizations have relied on the...

Indian Pharma Market (IPM) Highlights – January 2025

Overall IPM Performance: Monthly Growth: IPM monthly growth reached 8.4% in...

Role of AI Across Pharma Industry

Introduction Artificial intelligence (AI) is increasingly pivotal in driving innovation...
spot_img

Related Articles

spot_imgspot_img